[
  {
    "ts": null,
    "headline": "The Department of Health - Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi",
    "summary": "During BIO International Convention in Boston USA, the Department of Health - Abu Dhabi , the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a...",
    "url": "https://finnhub.io/api/news?id=464b03d1d7758759bbe5b247d1a869187a29070ed74889a57bb8e6ed7855a31c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750352729,
      "headline": "The Department of Health - Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi",
      "id": 135401514,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "During BIO International Convention in Boston USA, the Department of Health - Abu Dhabi , the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a...",
      "url": "https://finnhub.io/api/news?id=464b03d1d7758759bbe5b247d1a869187a29070ed74889a57bb8e6ed7855a31c"
    }
  },
  {
    "ts": null,
    "headline": "Is Trending Stock Abbott Laboratories (ABT) a Buy Now?",
    "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=697c84aabfa9fdd1f6c3206a6836d856e2167ea8fd13b930fe7f7dbca06ccb8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750338002,
      "headline": "Is Trending Stock Abbott Laboratories (ABT) a Buy Now?",
      "id": 135396861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=697c84aabfa9fdd1f6c3206a6836d856e2167ea8fd13b930fe7f7dbca06ccb8e"
    }
  },
  {
    "ts": null,
    "headline": "ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?",
    "summary": "Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood.",
    "url": "https://finnhub.io/api/news?id=61e7835bcd50a75ce98b842ffceb207ba84aec195162922e115ed1f99f89fe07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750335480,
      "headline": "ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?",
      "id": 135396862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood.",
      "url": "https://finnhub.io/api/news?id=61e7835bcd50a75ce98b842ffceb207ba84aec195162922e115ed1f99f89fe07"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) is a favorite amongst institutional investors who own 81%",
    "summary": "Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...",
    "url": "https://finnhub.io/api/news?id=af84d24d17422b8f65c5f15ba84151543edf4ea68d13d7c167b87a3e9df55207",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750330811,
      "headline": "Abbott Laboratories (NYSE:ABT) is a favorite amongst institutional investors who own 81%",
      "id": 135388451,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...",
      "url": "https://finnhub.io/api/news?id=af84d24d17422b8f65c5f15ba84151543edf4ea68d13d7c167b87a3e9df55207"
    }
  },
  {
    "ts": null,
    "headline": "Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor",
    "summary": "IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's future dual glucose-ketone sensor in the U.S. The iLet represents a significant advancement in diabetes care as the first and only AID system that makes 100% of insulin dosing decisions automatically. With the iLet, people living wi",
    "url": "https://finnhub.io/api/news?id=99a351a1959749d68d4808a50856703be22bac8e5c98124a70461d6898b4e5c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750330800,
      "headline": "Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor",
      "id": 135388066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's future dual glucose-ketone sensor in the U.S. The iLet represents a significant advancement in diabetes care as the first and only AID system that makes 100% of insulin dosing decisions automatically. With the iLet, people living wi",
      "url": "https://finnhub.io/api/news?id=99a351a1959749d68d4808a50856703be22bac8e5c98124a70461d6898b4e5c3"
    }
  }
]